n/a
Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy Number / Pilotto S.; Bria E.; Peretti U.; Massari F.; Garassino M.; Pelosi G.; Tortora G.. - In: JOURNAL OF THORACIC ONCOLOGY. - ISSN 1556-0864. - ELETTRONICO. - 8:12(2013), pp. 105-106. [10.1097/JTO.0b013e3182a00e37]
Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy Number
Massari F.;
2013
Abstract
n/aFile in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
